Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Jabs

Showing results (201-210 of 367) with videos related to

Pageof 37
Sort By:
JAMA|May 7, 2017
Association Between Long-Lasting Intravitreous Fluocinolone Acetonide Implant vs Systemic Anti-inflammatory Therapy and Visual Acuity at 7 Years Among Patients With Intermediate, Posterior, or Panuveitis, John H Kempen, Michael M Altaweel, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|April 16, 2003
Risk of vision loss in patients with cytomegalovirus retinitis and the acquired immunodeficiency syndromeJohn H Kempen, Douglas A Jabs, Laura A Wilson, et al.
Ophthalmology|April 6, 2005
Clinician versus reading center assessment of cytomegalovirus retinitis lesion sizeDavid V Weinberg, Janet T Holbrook, Larry D Hubbard, et al.
AIDS (London, England)|March 29, 2002
HIV and cytomegalovirus viral load and clinical outcomes in AIDS and cytomegalovirus retinitis patients: Monoclonal Antibody Cytomegalovirus Retinitis TrialDouglas A Jabs, Adele M Kaplan Gilpin, Yuan-I Min, et al.
Retina (Philadelphia, Pa.)|April 13, 2004
Complications of ganciclovir implant surgery in patients with cytomegalovirus retinitis: the Ganciclovir Cidofovir Cytomegalovirus Retinitis TrialJames P Dunn, Mark Van Natta, Gregory Foster, et al.
Ophthalmology|January 30, 2007
Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollmentDouglas A Jabs, Mark L Van Natta, Janet T Holbrook, et al.
Ophthalmic Epidemiology|March 1, 1997
Viral resistance and CMV retinitis: design and methods of a prospective study. CRVR Research Groups. Cytomegalovirus Retinitis Viral Resistance Research GroupC Enger, D A Jabs, J P Dunn, et al.
American Journal of Ophthalmology|August 25, 2011
Identifying a clinically meaningful threshold for change in uveitic macular edema evaluated by optical coherence tomographyElizabeth A Sugar, Douglas A Jabs, Michael M Altaweel, et al.
Cellular Immunology|March 1, 1994
Effects of early and late treatment with anti-CD4 monoclonal antibody on autoimmune disease in MRL/MP-lpr/lpr miceD A Jabs, R C Kuppers, A M Saboori, et al.
Ophthalmology Science|June 16, 2025
Plasma Proteomic Markers of Interleukin-1β Pathway Associated with Incident Age-Related Macular Degeneration in Persons with AIDSPeter W Hunt, Adam B Olshen, Natalia Murad, et al.
Pageof 37

Showing results (201-210 of 367) with videos related to

Sort By:
Pageof 37
JAMA|May 7, 2017
Association Between Long-Lasting Intravitreous Fluocinolone Acetonide Implant vs Systemic Anti-inflammatory Therapy and Visual Acuity at 7 Years Among Patients With Intermediate, Posterior, or Panuveitis, John H Kempen, Michael M Altaweel, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|April 16, 2003
Risk of vision loss in patients with cytomegalovirus retinitis and the acquired immunodeficiency syndromeJohn H Kempen, Douglas A Jabs, Laura A Wilson, et al.
Ophthalmology|April 6, 2005
Clinician versus reading center assessment of cytomegalovirus retinitis lesion sizeDavid V Weinberg, Janet T Holbrook, Larry D Hubbard, et al.
AIDS (London, England)|March 29, 2002
HIV and cytomegalovirus viral load and clinical outcomes in AIDS and cytomegalovirus retinitis patients: Monoclonal Antibody Cytomegalovirus Retinitis TrialDouglas A Jabs, Adele M Kaplan Gilpin, Yuan-I Min, et al.
Retina (Philadelphia, Pa.)|April 13, 2004
Complications of ganciclovir implant surgery in patients with cytomegalovirus retinitis: the Ganciclovir Cidofovir Cytomegalovirus Retinitis TrialJames P Dunn, Mark Van Natta, Gregory Foster, et al.
Ophthalmology|January 30, 2007
Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollmentDouglas A Jabs, Mark L Van Natta, Janet T Holbrook, et al.
Ophthalmic Epidemiology|March 1, 1997
Viral resistance and CMV retinitis: design and methods of a prospective study. CRVR Research Groups. Cytomegalovirus Retinitis Viral Resistance Research GroupC Enger, D A Jabs, J P Dunn, et al.
American Journal of Ophthalmology|August 25, 2011
Identifying a clinically meaningful threshold for change in uveitic macular edema evaluated by optical coherence tomographyElizabeth A Sugar, Douglas A Jabs, Michael M Altaweel, et al.
Cellular Immunology|March 1, 1994
Effects of early and late treatment with anti-CD4 monoclonal antibody on autoimmune disease in MRL/MP-lpr/lpr miceD A Jabs, R C Kuppers, A M Saboori, et al.
Ophthalmology Science|June 16, 2025
Plasma Proteomic Markers of Interleukin-1β Pathway Associated with Incident Age-Related Macular Degeneration in Persons with AIDSPeter W Hunt, Adam B Olshen, Natalia Murad, et al.
Pageof 37